We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05270044
Brief Title: Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. (COLUMBUS-AD)
First Submitted : February 14, 2022
First Submitted that Met QC Criteria : February 25, 2022
First Posted : March 8, 2022
Last Update Submitted that Met QC Criteria : March 3, 2023
Last Update Posted : March 6, 2023